Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation

Rheumatology

Volumn 42, Issue 2, 2003, Pages 375-379

  Wulffraat, N M ^a   Rijkers, G T ^a   Elst, E ^a   Brooimans, R ^a   Kuis, W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Juvenile idiopathic arthritis; Perforin expression; Stem cell transplantation

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PERFORIN; SALAZOSULFAPYRIDINE;

ADOLESCENT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; ERYTHROPHAGOCYTOSIS; FEMALE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTOSIS; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; SYSTEMIC DISEASE;

ADOLESCENT; ANTIGENS, CD45; ARTHRITIS, JUVENILE RHEUMATOID; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; MALE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 0037293064     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg074     Document Type: Article

References (29)

1. Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE, eds. Textbook of pediatric rheumatology. Philadelphia: WB Saunders, 2001:218-322.
2. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
3. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129:750-4.
4. Goransdotter EK, Fadeel B, Nilsson-Ardnor S et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001; 68:590-7.
5. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44.
6. Henter JI, Arico M, Elinder G, Imashuku S, Janka G. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:417-33.
7. Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunol Today 2000;21:254-5.
8. Stepp SE, Dufourcq-Lagelouse R, Le Deist F et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-9.
9. Ohadi M, Lalloz MR, Sham P et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 1999;64:165-71.
10. Ramsey SE, Bolaria RK, Cabral DA, Malleson PN, Petty RE. Comparison of the criteria for the classification of childhood arthritis. J Rheumatol 2000;27:1283-6.
11. Wulffraat NM, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999;353:550-3.
12. Wulffraat NM, Sanders LA, Kuis W. Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2000;2:316-23.
13. Woo P. Cytokines in juvenile chronic arthritis. Rheum Dis Clin North Am 1997;23:491-8.
14. Wulffraat NM, Kamphuis SM, van der Net J, Brinkman D, ten Cate R, Kuis W. Autologous stem-cell transplantation in 12 cases with refractory juvenile arthritis. Osteologic Bull 2000;5:62-5.
15. Quartier P, Prieur AM, Fischer A. Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet 1999;353:1885-6.
16. Spielman J, Lee RK, Podack ER. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 1998;161:7063-70.
17. Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997;77:530-4.
18. Lichtenheld MG, Podack ER, Levy RB. Transgenic control of perforin gene expression. Functional evidence for two separate control regions. Clin Exp Immunol 1999;116:366-70.
19. Zhang Y, Lichtenheld MG. Non-killer cell-specific transcription factors silence the perforin promoter. J Immunol 1997;158:1734-41.
20. Zhang Y, Scordi I, Smyth MJ, Lichtenheld MG. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J Exp Med 1999;190:1297-308.
21. Yu CR, Ortaldo JR, Curiel RE, Young HA, Anderson SK, Gosselin P. Role of a STAT binding site in the regulation of the human perforin promoter. J Immunol 1999;162:2785-90.
22. Youn BS, Kim KK, Kwon BS. A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene. J Immunol 1996;157:3499-509.
23. Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994;91:11571-4.
24. Shustov A, Luzina I, Nguyen P, Papadimitriou JC, Handwerger B, Elkon KB, Via CS. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest 2000;106:39-47.
25. Peng SL, Moslehi J, Robert ME, Craft J. Perforin protects against autoimmunity in lupus-prone mice. J Immunol 1998;160:652-60.
26. Kagi D, Ledermann B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369:31-7.
27. van den Broek ME, Kagi D, Ossendorp F et al. Decreased tumor surveillance in perforin-deficient mice. J Exp Med 1996;184:1781-90.
28. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
29. Ruperto N, Ravelli A, Falcini F et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998;57:38-41.